Health-Holland

World-class research institutes, a highly educated workforce, an excellent healthcare system, and an innovation-friendly government, combined with a central location make the Netherlands the ultimate R&D innovation hub in Europe and the ideal base for your biopharmaceutical operations. At the Ministry of Economic Affairs and Climate Policy, we are proud of the Netherlands’ spirit of innovation and enterprise and we work hard to strengthen our international competitive position while striving for sustainability. The Top Sector Life Sciences and Health is one of the priority sectors in which the Ministry actively participates to create an attractive business climate, foster R&D collaboration and provides optimum conditions for businesses to innovate and grow. Innovation, entrepreneurship and partnership are second nature to the Dutch. It is connected to our centuries-old battle against the water – a way of life that has produced innovative and smart solutions, like our famous dikes, as well as a cooperative mindset. Our country is one of the main gateways to Europe. Thanks to our first-rate infrastructure, we offer excellent and efficient connections to Europe's 500 million consumers. Our world-class airport, top-ranked maritime ports and high-speed road, rail and broadband networks are second to none. We’re especially proud of the pharmaceutical sector, which plays an important role in our economy and acts as a breeding ground for new talent. Leading pharmaceutical companies like Janssen, AstraZeneca and Synthon are already conducting their R&D activities in the Netherlands. Others, including Amgen, Teva and MSD are taking advantage of our strategic location for their distribution activities. The Netherlands is also home to many promising start-ups and scale-ups such as Galapagos, Genmab, Pharming and uniQure. The relocation of EMA to Amsterdam in March 2019 will give a boost to the biopharmaceutical sector and put the Netherlands firmly on the map internationally. At the same time it will create huge opportunities for biopharmaceutical companies and service providers. The Ministry has joined forces with other organisations in PharmInvestHolland, to strengthen the Dutch biopharmaceutical sector and create the most attractive and innovative biopharmaceutical industry environment in Europe. I am pleased to present this bid book, illustrating all that the Netherlands can offer your company. I hope it will lead you to consider the Netherlands as a base for your pharmaceutical operations. Yours sincerely, Eric Wiebes Minister of Economic Affairs and Climate Policy FOREWORD Welcome to the Netherlands, the new home of the European Medicines Agency! 5